Haemonetics | HAE - Selling And Administration Expenses

Stock Price
60.64
Daily Change
-0.55 -0.90%
Monthly
-11.31%
Yearly
-8.01%
Q1 Forecast
59.29

Haemonetics reported $109.15M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Avanos Medical USD 77.6M 5.9M Sep/2025
Baxter International USD 761M 53M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Boston Scientific USD 1.83B 93M Dec/2025
Cerus USD 19.33M 1.55M Dec/2024
Cooper Companies USD 419.2M 12M Sep/2025
Fresenius EUR 676M 64M Sep/2025
Fresenius Medical Care EUR 705.44M 86.56M Sep/2025
Globus Medical USD 313.6M 9.98M Sep/2025
Haemonetics USD 109.15M 7.54M Dec/2025
Hologic USD 2.5B 2.24B Dec/2025
ICU Medical USD 155.81M 3.04M Dec/2025
Intuitive Surgical USD 687.1M 113.8M Dec/2025
Masimo USD 116.4M 20.5M Sep/2025
Medtronic 2.97B 159M Sep/2025
Merit Medical Systems USD 107.38M 5.72M Sep/2025
Neogen USD 107.5M 1.56M Sep/2025
OraSure Technologies USD -0.06 0.05 Sep/2024
Quidel USD 194.4M 7.5M Dec/2025
ResMed USD 278.4M 19.2M Dec/2025
STAAR Surgical USD 59.38M 18.08M Sep/2025
Steris USD 352.3M 2.6M Dec/2025
Stryker USD 2.14B 150M Dec/2025
Surmodics USD 14.58M 2.05M Sep/2024
Teleflex USD 281.76M 66.68M Sep/2025
Terumo JPY 105.26B 7.38B Dec/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
US Physical Therapy USD 17.41M 62K Sep/2025
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025